Jackson, Grant Investment Advisers, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
Jackson, Grant Investment Advisers, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$29,960
-16.9%
5000.0%0.01%
-17.6%
Q2 2023$36,050
-2.0%
5000.0%0.02%0.0%
Q1 2023$36,780
+10.1%
5000.0%0.02%
+6.2%
Q4 2022$33,400
-22.3%
5000.0%0.02%
-27.3%
Q3 2022$43,000
-4.4%
5000.0%0.02%0.0%
Q2 2022$45,000
-19.6%
5000.0%0.02%
-8.3%
Q1 2022$56,000
-27.3%
5000.0%0.02%
-38.5%
Q4 2021$77,000
+10.0%
5000.0%0.04%
+25.8%
Q3 2021$70,000
+6.1%
5000.0%0.03%
+6.9%
Q2 2021$66,000
-13.2%
5000.0%0.03%
-17.1%
Q1 2021$76,000
+52.0%
5000.0%0.04%
+34.6%
Q4 2020$50,000
+4.2%
5000.0%0.03%
-10.3%
Q3 2020$48,000
-14.3%
5000.0%0.03%
-19.4%
Q2 2020$56,000
+55.6%
5000.0%0.04%
+33.3%
Q1 2020$36,000
-30.8%
5000.0%0.03%
-3.6%
Q4 2019$52,000
+4.0%
5000.0%0.03%0.0%
Q3 2019$50,000
-12.3%
5000.0%0.03%
-15.2%
Q2 2019$57,000
-9.5%
5000.0%0.03%
-13.2%
Q1 2019$63,000
-7.4%
5000.0%0.04%
-20.8%
Q4 2018$68,000
-50.4%
5000.0%0.05%
-44.2%
Q3 2018$137,0005000.09%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders